Cas 880-03-5,Benzene, 1-(methoxymethoxy)-4-nitro-

880-03-5

Post Buying Request

Basic information

Product Name: Benzene, 1-(methoxymethoxy)-4-nitro-
Synonyms:
CAS NO:880-03-5
Molecular Formula: C8H9NO4
Molecular Weight: 183.164
EINECS: N/A
Product Categories: N/A
Mol File: 880-03-5.mol
Article Data: 16

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzene, 1-(methoxymethoxy)-4-nitro-(CAS DataBase Reference)
NIST Chemistry Reference: Benzene, 1-(methoxymethoxy)-4-nitro-(880-03-5)
EPA Substance Registry System: Benzene, 1-(methoxymethoxy)-4-nitro-(880-03-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 880-03-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

880-03-5 Suppliers

Recommended suppliersmore

880-03-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 880-03-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,8 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 880-03:
(5*8)+(4*8)+(3*0)+(2*0)+(1*3)=75
75 % 10 = 5
So 880-03-5 is a valid CAS Registry Number.

880-03-5Upstream product

880-03-5Downstream Products

880-03-5Relevant articles and documents

Synthesis and Biological Evaluation of Novel Substituted 4-Anilinoquinazolines as Antitumor Agents

Cao, Dong,Wang, Xiaoyan,Lei, Lei,Ma, Liang,Yang, Zhuang,Wang, Fang,Chen, Lijuan

, p. 1084 - 1094 (2020/12/02)

Eleven novel 4-anilinoquinazoline derivatives were synthesized and evaluated for their in?vitro antiproliferative activity. Among them, compound 9a exhibited the best potency, with IC50 values of 25?682?nm against various types of cancer cell l

HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

-

Paragraph 0230-0231, (2018/04/20)

A compound represented by Formula I or pharmaceutically acceptable salt thereof. The present invention relates to a 4-arylamino quinazoline hydroxamic acid compound having a histone deacetylase inhibitory activity, preparation method of the compound, pharmaceutical composition comprising the compound, and use of the compound and the pharmaceutical composition in the preparation of a histone deacetylase inhibitor medicine. The present invention aims at acquiring, via a medicine design and a synthetic technology, a series of selective histone deacetylase inhibitors having good hypotype selectivity and favorable pharmacokinetic characteristics based on optimization of an enzyme surface recognition region and connection region of 4-arylamino quinazoline, thus reducing an effect on normal tissues or cells while improving an antineoplastic activity of the normal tissues or cells.

Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer

Yang, Zhuang,Wang, Taijin,Wang, Fang,Niu, Ting,Liu, Zhuowei,Chen, Xiaoxin,Long, Chaofeng,Tang, Minghai,Cao, Dong,Wang, Xiaoyan,Xiang, Wei,Yi, Yuyao,Ma, Liang,You, Jingsong,Chen, Lijuan

, p. 1455 - 1470 (2016/03/08)

Novel selective histone deacetylase 6 (HDAC6) inhibitors using the quinazoline as the cap were designed, synthesized, and evaluated for HDAC enzymatic assays. N-Hydroxy-4-(2-methoxy-5-(methyl(2-methylquinazolin-4-yl)amino)phenoxy)butanamide, 23bb, was the

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 880-03-5